American Diabetes Association (ADA) Annual Meeting

Date not specified — The American Diabetes Association (ADA) outlines its Abstract Embargo Policy for the 2026 Scientific Sessions. All attendees, media, companies, institutions, and other parties must keep information from any abstract or presentation confidential until the stated embargo lifts; this applies across all distribution channels (meeting app/planner, USB, journal Diabetes website, and other methods). The policy is intended to protect scientific integrity, as submissions are considered preliminary until presentation or authorized release. Violations can result in removal from the meeting and a two-year ban for the individual and their affiliated organization.

Key embargo timings: oral presentation abstracts remain embargoed until the scheduled start of the talk; poster (including late-breaking) abstracts until Friday, June 5, 2026 at 6:30 PM CT; symposia until the symposium start; “Published Only” abstracts until Friday, June 5, 2026 at 10:30 AM CT. Most embargoed abstract text will be available in the app starting May 29, 2026 for planning, but embargo restrictions still apply. Publicly traded companies may request a limited SEC-related exception to release top-line data, subject to ADA review and conditions.